PD-1 and LAG-3 as early prognostic markers in the treatment of patients with chronic lymphocytic leukemia

PD-1 and LAG-3 as early prognostic markers in the treatment of patients with chronic lymphocytic leukemia

Background. Recently, studies have been conducted all over the world to study the role of immune checkpoints in the pathogenesis of chronic lymphocytic leukemia (CLL) and the possibility of their use as prognostic markers. Of greatest interest are PD-1 (programmed cell death-1) and LAG-3 protein (ly...

Full description

Saved in:
Bibliographic Details
Main Authors: O. N. Selyutina, I. B. Lysenko, N. K. Guskova, I. А. Novikova, E. Yu. Zlatnik, T. F. Pushkareva, N. V. Nikolaeva, I. A. Kamaeva, E. A. Kapuza, Ya. S. Gaysultanova, L. Ya. Rozenko
Format: Article
Language:Russian
Published: ABV-press 2023-12-01
Series:Онкогематология
Subjects:
chronic lymphocytic leukemia
lag-3
pd-1
lymphocyte count
minimal residual disease
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/876
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://oncohematology.abvpress.ru/ongm/article/view/876

Similar Items